tiprankstipranks
Trending News
More News >
Fate Therapeutics (FATE)
NASDAQ:FATE

Compare Fate Therapeutics (FATE) vs. Competitors

Compare
1,256 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Fate Therapeutics
$1.08
$124.58M
-0.82
-13.94%
5 Buy
4 Hold
0 Sell
Moderate Buy
Compugen
$1.98
$185.20M
-6.62
-1.00%
2 Buy
0 Hold
0 Sell
Moderate Buy
Oncolytics Biotech
$1.05
$112.99M
-3.74
29.63%
5 Buy
1 Hold
0 Sell
Strong Buy
Cardiff Oncology
$2.81
$189.28M
-14.59%
6 Buy
0 Hold
0 Sell
Strong Buy
Nkarta
$2.07
$147.03M
-1.49
-6.33%
4 Buy
1 Hold
0 Sell
Strong Buy
Shattuck Labs
$4.73
$299.31M
-4.64
322.32%
2 Buy
2 Hold
0 Sell
Moderate Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
FATE
Fate Therapeutics
1.08
-0.17
-13.60%
CGEN
Compugen
1.98
-0.14
-6.60%
ONCY
Oncolytics Biotech
1.05
0.21
25.30%
TSE:ONC
CRDF
Cardiff Oncology
2.81
-0.59
-17.35%
NKTX
Nkarta
2.07
-0.42
-16.87%
STTK
Shattuck Labs
4.73
3.64
333.94%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts